New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody
Modern Rheumatology · 2023
DOI: 10.1093/mr/road011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Yuji Hosono und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan. Hauptthemen laut MEDLINE: Dermatomyositis, Lung Diseases, Interstitial, Sjogren's Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objectives
Anti-asparaginyl tRNA synthetase (anti-KS) antibody is present in patients with interstitial lung disease (ILD) accompanied by polymyositis/dermatomyositis. We examined clinical/immunological features of these patients.
Methods
Polymyositis/dermatomyositis or ILD patients were screened for autoantibodies, and clinical/immunological data were collected retrospectively. ILD was diagnosed by computed tomography, and clinical/immunological features of anti-KS-positive patients were compared with those of anti-Jo-1-positive patients.
Results
Sixteen anti-KS-positive patients [female = 11; male = 5; average age 63.6 years (range, 40–81) years] were diagnosed: seven had ILD, four had clinically amyopathic DM (CADM) and ILD, three had Sjögren’s syndrome (SS) and ILD one each had rheumatoid arthritis and ILD, or CADM/SS overlap and ILD. All patients had ILD with chronic onset and clinical course; 11/16 (69%) had nonspecific interstitial pneumonia, and five (31%) had usual interstitial pneumonia pattern. Regarding skin manifestations, 4 (27%) had typical DM rash and 11 (69%) had mechanic’s hands. All anti-KS-positive patients had no clinical muscle weakness or serum creatine kinase elevation; 8/16 patients (50%) had sicca symptoms at a significantly high frequency compared with anti-Jo-1-positive patients (50% vs 11%, P = 0.01).
Conclusions
Anti-KS-positive patients might form a distinguishable subset closely associated with sicca symptoms, CADM and chronic-type ILD with a relatively favourable prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
- Department of Rheumatology, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan.
Zitieren
APA
Hosono, Y., Ishii, A., Izumi, Y., Sasaki, N., Nogi, S., Yamada, C., & Sato, S. (2023). New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody. Modern Rheumatology. https://doi.org/10.1093/mr/road011
Vancouver
Hosono Y, Ishii A, Izumi Y, Sasaki N, Nogi S, Yamada C, et al. New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody. Modern Rheumatology. 2023. doi:10.1093/mr/road011
BibTeX
@article{Hosono2023,
author = {Hosono, Yuji and Ishii, Akira and Izumi, Yuto and Sasaki, Noriko and Nogi, Shinichi and Yamada, Chiho and Sato, Shinji},
title = {New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/road011}
}
EUVIMED